Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v2-FR
Language French French
Date Updated 2022-07-29 2022-05-12
Drug Identification Number 00039500 00039500
Brand name NORMOSOL-R NORMOSOL-R
Common or Proper name Multiple Electrolytes Injection Type 1 USP Multiple Electrolytes Injection Type 1 USP
Company Name ICU MEDICAL CANADA INC ICU MEDICAL CANADA INC
Ingredients SODIUM GLUCONATE SODIUM ACETATE SODIUM CHLORIDE MAGNESIUM CHLORIDE POTASSIUM CHLORIDE SODIUM GLUCONATE SODIUM ACETATE SODIUM CHLORIDE MAGNESIUM CHLORIDE POTASSIUM CHLORIDE
Strength(s) 0.502G 0.222G 0.526G 0.014G 0.037G 0.502G 0.222G 0.526G 0.014G 0.037G
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 1000 mL 1000 mL
ATC code B05BB B05BB
ATC description I.V. SOLUTIONS I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-06-15 2022-05-31
Actual start date
Estimated end date 2022-07-29 2022-07-29
Actual end date 2022-07-29
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments